Skip to content

This text should not show on a preview page

The information on this site is for healthcare professionals only.
Are you a healthcare professional?

No
This site is not currently optimised for Internet Explorer.
For best viewing, please use Chrome, Firefox, Edge, or Safari.
  • Let's talk  Knowledge
  • Let's talk  Events
  • Let's talk  Innovation
  • Let's talk  Videos
  • Let's talk  Key opinions
  • Let's talk  Teva
  • Let's talk  Sign up
  • Let's talk  Knowledge
  • Let's talk  Events
  • Let's talk  Innovation
  • Let's talk  Videos
  • Let's talk  Key opinions
  • Let's talk  Teva
  • Let's talk  Sign up
  • Home
  • Videos

Let's talk Videos

ERS 2020: COPD management and connected inhalers

ERS 2020: COPD management and connected inhalers

Events
ERS 2020: Connected inhalers in the clinic

ERS 2020: Connected inhalers in the clinic

Events
Peter Barnes at ERS 2019

Peter Barnes at ERS 2019

Videos
Sinthia Bosnic-Anticevich at ERS 2019

Sinthia Bosnic-Anticevich at ERS 2019

Videos
Meet the Experts Highlights at ERS 2019

Meet the Experts Highlights at ERS 2019

Videos
Highlights from ERS Congress 2019

Highlights from ERS Congress 2019

  • Congress
Videos 1 min read
ERS 2018: Prof Richard Dekhuijzen on adherence

ERS 2018: Prof Richard Dekhuijzen on adherence

  • Adherance
Videos 2 min read
ERS 2018: Prof Richard Costello on LAMAs

ERS 2018: Prof Richard Costello on LAMAs

  • Asthma
  • Treatment
Videos 1 min read
ERS 2018: Prof Richard Dekhuijzen

ERS 2018: Prof Richard Dekhuijzen

  • Inhalers
  • Technology
Videos 2 min read
ERS 2018: Prof Richard Costello

ERS 2018: Prof Richard Costello

  • Technology
Videos 2 min read
Filter

Disease management

Technology

Therapy area

  • Let's talk  Contact
  • Let's talk  Legal notice
  • Let's talk  Privacy policy
  • Let's talk  Report Adverse Events
© 2021 Teva Pharmaceuticals Europe BV. All rights reserved. Reporting of suspected adverse events is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. To ensure correct adverse event reporting, healthcare professionals are encouraged to use the appropriate website for their National Authority.
Piet Heinkade 107, 1019 GM Amsterdam, The Netherlands.
Approval code: HQ/RESP/19/0001a Date of preparation: May 2019

This website uses cookies to ensure you get the best experience on our website. Learn more in our cookie policy

Thank you for your visit.
You are now leaving the website.
Do you wish to continue?